Thus, this new knowledge extends the mechanisms underlying the role of the Ehmt2-mediated pathway in suppressing pancreatic cancer initiation and modulating inflammatory pancreatic diseases. The gene discussed is EHMT2; the disease is familial pancreatic carcinoma.